西安国康瑞金制药

Xi'an Guokang Ruijin Pharmaceutical is a pharmaceutical enterprise based in the High-tech Industrial Development Zone of Xi'an, China. Founded in 2001, the company specializes in the research, development, and manufacturing of drugs primarily focused on cardiovascular and cerebrovascular health. Its flagship product, Ruijin Capsules, is widely recognized in the Chinese market for treating conditions related to blood stasis and coronary heart disease. The company operates GMP-certified production lines for various formulations, including capsules, tablets, and granules, ensuring high standards of quality and safety. Guokang Ruijin integrates traditional medicinal knowledge with modern pharmaceutical technology to serve the healthcare needs of the domestic population.